Global Microarray Biochips Market Growth 2025-2031

The global Microarray Biochips market size is predicted to grow from US$ 1385 million in 2025 to US$ 2353 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.

Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.

Illumina and Thermo Fisher Scientific are the two largest companies in the industry, accounting for more than 74 percent of 2018 revenue combined. In terms of production value, the United States occupies the absolute position, with production value accounting for more than 86%.

LP Information, Inc. (LPI) ' newest research report, the “Microarray Biochips Industry Forecast” looks at past sales and reviews total world Microarray Biochips sales in 2024, providing a comprehensive analysis by region and market sector of projected Microarray Biochips sales for 2025 through 2031. With Microarray Biochips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microarray Biochips industry.

This Insight Report provides a comprehensive analysis of the global Microarray Biochips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microarray Biochips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microarray Biochips market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microarray Biochips and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microarray Biochips.

This report presents a comprehensive overview, market shares, and growth opportunities of Microarray Biochips market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
DNA Microarray
Protein Microarray
Other

Segmentation by Application:
Drug Discovery
Research
Diagnostics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
Bio-Rad Laboratories
PerkinElmer
BioChain
Sengenics
Applied Microarrays
US Biomax

Key Questions Addressed in this Report

What is the 10-year outlook for the global Microarray Biochips market?

What factors are driving Microarray Biochips market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Microarray Biochips market opportunities vary by end market size?

How does Microarray Biochips break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.